Stratec SE (LTS:0RAR) EPS (Diluted): €-0.28 (TTM As of Mar. 2026)


LTS:0RAR Stratec SE LTS:0RAR
62 GF Score
Price €19.30
GF Value €32.37
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Stratec SE EPS (Diluted)?

Stratec SE LTS:0RAR +3.76% 62 EPS (Diluted) is €-0.28 as of Mar. 2026. GuruFocus rates LTS:0RAR with a GF Score™ of 62/100 and a GF Value™ of €32.37 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Stratec SE's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was €-0.14. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.28.

Stratec SE's EPS (Basic) for the three months ended in Mar. 2026 was €-0.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.28.

Stratec SE's EPS without NRI for the three months ended in Mar. 2026 was €-0.14. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was €0.73.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Stratec SE  (LTS:0RAR) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Stratec SE EPS (Diluted) Related Terms


Stratec SE EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Stratec SE's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stratec SE EPS (Diluted) Chart

Stratec SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.28 2.40 1.26 1.32 -0.02

Stratec SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.09 0.13 -0.36 -0.14

LTS:0RAR vs ABT, SYK, MDT: EPS (Diluted) Comparison

For the Medical Devices subindustry, Stratec SE's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's PE Ratio distribution charts can be found below:

* The bar in red indicates where Stratec SE's PE Ratio falls into.


LTS:0RAR
62GF Score
Stratec SE LTS:0RAR
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stratec SE EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Stratec SE's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.242-0)/12.156
=-0.02

Stratec SE's Diluted EPS for the quarter that ended in Mar. 2026 is calculated as

Diluted EPS (Q: Mar. 2026 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.713-0)/12.156
=-0.14

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of €-0.28 mean?
Stratec SE (LTS:0RAR) has a EPS (Diluted) of €-0.28 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Stratec SE and its competitors.
Is Stratec SE's EPS (Diluted) too high?
Stratec SE's current EPS (Diluted) is €-0.28. Overall, Stratec SE has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stratec SE's EPS (Diluted) compare to ABT and SYK?
Stratec SE's EPS (Diluted) of €-0.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Devices & Instruments company?
A good EPS (Diluted) depends on the Medical Devices & Instruments industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Stratec SE and its competitors. Stratec SE's current EPS (Diluted) is €-0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stratec SE stock overvalued right now?
Based on GuruFocus' analysis, Stratec SE (LTS:0RAR) is currently considered Significantly Undervalued. The stock's GF Value™ is €32.37, compared to a current price of €19.30 — trading 40.4% below its estimated fair value. The current EPS (Diluted) is €-0.28. Stratec SE's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Stratec SE (LTS:0RAR), the current EPS (Diluted) is €-0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stratec SE (LTS:0RAR) Overvalued in 2026?

Based on GuruFocus' analysis, Stratec SE stock appears to be undervalued. The current stock price of €19.30 is trading 40.4% below its estimated GF Value™ of €32.37. GuruFocus considers Stratec SE to be Significantly Undervalued.

Key valuation signals for LTS:0RAR:

  • EPS (Diluted): €-0.28
  • GF Value™: €32.37 vs. price of €19.30 (40.4% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stratec SE Business Description

Other Exchanges SBS:GermanySBSG:Austria
Address Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automation solutions for regulated laboratory markets. STRATEC acts as an OEM partner to players in the in-vitro diagnostics and life sciences markets. The Group's product range includes both hardware solutions, software solutions, and related consumables, as well as independently marketed consumables. These products are mostly combined into fully integrated system solutions and often receive market approval together with partners' reagents.
62GF Score

Get the complete analysis for LTS:0RAR

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.30
Price
€32.37
GF Value